03:46 AM EDT, 05/06/2025 (MT Newswires) -- Sean Maduck, President, Corcept Endocrinology, on May 01, 2025, sold 39,410 shares in Corcept Therapeutics ( CORT ) for $2,842,769. Following the Form 4 filing with the SEC, Maduck has control over a total of 105,622 common shares of the company, with 85,622 shares held directly and 20,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000095017025063835/xslF345X05/ownership.xml